Literature DB >> 11028577

Expectant management of early onset, severe pre-eclampsia: maternal outcome.

D R Hall1, H J Odendaal, D W Steyn, D Grové.   

Abstract

OBJECTIVE: To evaluate the safety and outcome of women undergoing expectant management of early onset, severe pre-eclampsia.
DESIGN: Prospective case series extending over a five-year period.
SETTING: Tygerberg Hospital, a tertiary referral centre. POPULATION: All women (n = 340) presenting with early onset, severe pre-eclampsia, where both the mother and the fetus were otherwise stable.
METHODS: Frequent clinical and biochemical monitoring of maternal status, together with careful blood pressure control, in a high care obstetric ward. MAIN OUTCOME MEASURES: Major maternal complications and prolongation of gestation.
RESULTS: Multigravid women constituted 67% of the group. Antenatal biochemistry was reassuring with some expected, but not severe, deteriorations. Twenty-seven percent of women experienced a major complication, but few had poor outcomes. No maternal deaths occurred. Most major complications resolved quickly, necessitating only three admissions (0.8%) to the intensive care unit. One woman required dialysis. Pregnancies were prolonged by a mean (median) number of 11 days (9) before delivery, with more time being gained at earlier gestations. The postpartum inpatient stay (89% < or =7 days, bearing in mind that 82% of women were delivered by caesarean section) was not extended.
CONCLUSION: Careful noninvasive management of early onset, severe pre-eclampsia in a tertiary centre can diminish and limit the impact of serious maternal complications. Valuable time to prolong the pregnancy and improve neonatal outcome is thereby gained.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028577     DOI: 10.1111/j.1471-0528.2000.tb11616.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  9 in total

1.  Severe preterm preeclampsia: an examination of outcomes by race.

Authors:  Jessica A Peterson; Kirsten Sandgren; Lisa D Levine
Journal:  Am J Obstet Gynecol MFM       Date:  2020-07-22

2.  Maternal and perinatal outcome during expectant management of severe pre-eclampsia between 24 and 34 weeks of gestation.

Authors:  M K Swamy; Kamal Patil; Shailaja Nageshu
Journal:  J Obstet Gynaecol India       Date:  2012-10-23

3.  The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia.

Authors:  Renate Hillermann; Kashefa Carelse; G Stefan Gebhardt
Journal:  J Hum Genet       Date:  2005-07-30       Impact factor: 3.172

4.  Does aggressive and expectant management of severe preeclampsia affect the neurologic development of the infant?

Authors:  Arif Aktuğ Ertekin; Bilge Kapudere; Meryem Kurek Eken; Gülşah İlhan; Şükriye Dırman; Mehmet Akif Sargın; Engin Deniz; Güner Karatekin; Ebru Çöğendez; Murat Api
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity.

Authors:  Kartik K Venkatesh; Robert A Strauss; Daniel J Westreich; John M Thorp; David M Stamilio; Katherine L Grantz
Journal:  Pregnancy Hypertens       Date:  2020-03-10       Impact factor: 2.899

6.  Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction.

Authors:  Haruki Nishizawa; Sayuri Ota; Machiko Suzuki; Takema Kato; Takao Sekiya; Hiroki Kurahashi; Yasuhiro Udagawa
Journal:  Reprod Biol Endocrinol       Date:  2011-08-02       Impact factor: 5.211

7.  Maternal and fetal outcome of pregnancy related hypertension in Mettu Karl Referral Hospital, Ethiopia.

Authors:  Eshetu Seyom; Mubarek Abera; Million Tesfaye; Netsanet Fentahun
Journal:  J Ovarian Res       Date:  2015-03-15       Impact factor: 4.234

8.  Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol.

Authors:  Catherine A Cluver; Susan P Walker; Ben W Mol; Gerard B Theron; David R Hall; Richard Hiscock; N Hannan; S Tong
Journal:  BMJ Open       Date:  2015-10-28       Impact factor: 2.692

9.  Prevalence of hypertensive disorders of pregnancy and pregnancy outcomes in Sub-Saharan Africa: A systematic review and meta-analysis.

Authors:  Kasiye Shiferaw Gemechu; Nega Assefa; Bizatu Mengistie
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.